| Primary |
| Hiv Infection |
62.6% |
| Drug Use For Unknown Indication |
7.7% |
| Antiretroviral Therapy |
7.0% |
| Hepatitis B |
6.7% |
| Acquired Immunodeficiency Syndrome |
2.7% |
| Antiviral Prophylaxis |
2.5% |
| Retroviral Infection |
1.3% |
| Hypertension |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Tuberculosis |
1.0% |
| Antiviral Treatment |
1.0% |
| Hiv Test Positive |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Prophylaxis |
0.7% |
| Immunosuppression |
0.6% |
| Human Immunodeficiency Virus Transmission |
0.6% |
| Chronic Hepatitis |
0.5% |
| Gastritis |
0.5% |
| B-cell Lymphoma |
0.4% |
| Device Related Infection |
0.4% |
|
| Vomiting |
13.8% |
| Stillbirth |
8.2% |
| Drug Exposure During Pregnancy |
7.2% |
| Hepatitis B |
6.7% |
| Weight Decreased |
6.7% |
| Immune Reconstitution Syndrome |
6.2% |
| Viral Infection |
5.6% |
| Nausea |
4.6% |
| Maternal Drugs Affecting Foetus |
4.1% |
| Treatment Failure |
4.1% |
| Viral Load Increased |
4.1% |
| Abortion Spontaneous |
3.6% |
| Progressive Multifocal Leukoencephalopathy |
3.6% |
| Nervous System Disorder |
3.1% |
| Pulmonary Embolism |
3.1% |
| Pyrexia |
3.1% |
| Renal Injury |
3.1% |
| Splenomegaly |
3.1% |
| Therapeutic Response Decreased |
3.1% |
| Thrombocytopenia |
3.1% |
|
| Secondary |
| Hiv Infection |
60.1% |
| Antiretroviral Therapy |
6.4% |
| Drug Use For Unknown Indication |
5.4% |
| Prophylaxis |
4.2% |
| Human Immunodeficiency Virus Transmission |
3.3% |
| Product Used For Unknown Indication |
2.8% |
| Drug Exposure During Pregnancy |
2.7% |
| Tuberculosis |
2.4% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Prophylaxis Against Hiv Infection |
2.0% |
| Hiv Test Positive |
1.6% |
| Antiviral Prophylaxis |
1.3% |
| Antifungal Prophylaxis |
1.1% |
| Hepatitis B |
1.0% |
| Hepatitis C |
1.0% |
| Hypertension |
0.8% |
| Systemic Antiviral Treatment |
0.5% |
| Prophylaxis Against Transplant Rejection |
0.5% |
| Insomnia |
0.5% |
| Maternal Exposure During Pregnancy |
0.4% |
|
| Vomiting |
13.2% |
| Weight Decreased |
8.0% |
| Premature Baby |
7.2% |
| Immune Reconstitution Syndrome |
7.1% |
| Pregnancy |
6.8% |
| Drug Exposure During Pregnancy |
6.5% |
| Hiv Infection |
5.1% |
| Progressive External Ophthalmoplegia |
5.1% |
| Lactic Acidosis |
4.3% |
| Stillbirth |
4.3% |
| Pyrexia |
4.1% |
| White Blood Cell Count Decreased |
4.0% |
| Tuberculosis |
3.6% |
| Osteonecrosis |
3.4% |
| Death |
3.2% |
| Viral Mutation Identified |
3.2% |
| Portal Hypertension |
2.9% |
| Progressive Multifocal Leukoencephalopathy |
2.7% |
| Small For Dates Baby |
2.7% |
| Neutropenia |
2.7% |
|
| Concomitant |
| Hiv Infection |
56.4% |
| Drug Use For Unknown Indication |
12.1% |
| Product Used For Unknown Indication |
4.6% |
| Prophylaxis |
4.3% |
| Hepatitis B |
3.4% |
| Hypertension |
2.4% |
| Acquired Immunodeficiency Syndrome |
2.2% |
| Antiretroviral Therapy |
2.0% |
| Antifungal Prophylaxis |
1.5% |
| Antibiotic Prophylaxis |
1.4% |
| Diarrhoea |
1.2% |
| Mycobacterium Avium Complex Infection |
1.1% |
| Hepatic Neoplasm Malignant |
1.1% |
| Tuberculosis |
1.0% |
| Antiviral Prophylaxis |
1.0% |
| Pneumocystis Jiroveci Pneumonia |
0.9% |
| Hiv Test Positive |
0.9% |
| Prophylaxis Against Transplant Rejection |
0.9% |
| Multiple Myeloma |
0.8% |
| Liver Transplant |
0.8% |
|
| Vomiting |
15.6% |
| Weight Decreased |
9.1% |
| Renal Failure |
6.9% |
| Pyrexia |
6.7% |
| Renal Failure Acute |
6.5% |
| Death |
5.6% |
| Thrombocytopenia |
5.0% |
| Rhabdomyolysis |
4.6% |
| Drug Interaction |
4.2% |
| Pneumonia |
4.1% |
| White Blood Cell Count Decreased |
4.0% |
| Hepatitis B |
3.9% |
| Pregnancy |
3.7% |
| Septic Shock |
3.5% |
| Renal Impairment |
3.2% |
| Viral Load Increased |
3.1% |
| Sepsis |
3.0% |
| Neutropenia |
2.5% |
| Respiratory Failure |
2.5% |
| Weight Increased |
2.3% |
|
| Interacting |
| Hiv Infection |
39.1% |
| Antiretroviral Therapy |
25.9% |
| Blood Pressure Management |
8.8% |
| Systemic Antiviral Treatment |
4.4% |
| Type 2 Diabetes Mellitus |
3.6% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Contraception |
2.6% |
| Hypertension |
2.6% |
| Neuropathy Peripheral |
2.2% |
| Opportunistic Infection Prophylaxis |
1.8% |
| Alcohol Abuse |
1.5% |
| Liver Transplant |
1.1% |
| Bronchospasm |
0.7% |
| Insomnia |
0.7% |
| Hepatic Neoplasm Malignant |
0.4% |
| Immunosuppression |
0.4% |
| Pemphigus |
0.4% |
| Product Used For Unknown Indication |
0.4% |
| Pulmonary Embolism |
0.4% |
| Rheumatoid Arthritis |
0.4% |
|
| Drug Interaction |
23.1% |
| Renal Failure Acute |
23.1% |
| Herpes Simplex |
5.1% |
| Multi-organ Failure |
5.1% |
| Skin Striae |
5.1% |
| Abdominal Pain |
2.6% |
| Amenorrhoea |
2.6% |
| Drug Metabolising Enzyme Test Abnormal |
2.6% |
| Ectopic Pregnancy |
2.6% |
| Embolism Venous |
2.6% |
| Incorrect Drug Administration Duration |
2.6% |
| Intentional Overdose |
2.6% |
| Nephropathy Toxic |
2.6% |
| Overdose |
2.6% |
| Peroneal Nerve Palsy |
2.6% |
| Pigmentation Disorder |
2.6% |
| Pregnancy With Implant Contraceptive |
2.6% |
| Sepsis |
2.6% |
| Toxicity To Various Agents |
2.6% |
| Tubulointerstitial Nephritis |
2.6% |
|
